| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/18/2006 | CN1279972C Purified cytokine inhibitory factor |
| 10/18/2006 | CN1279971C Novel method for down-regulation of amyloid |
| 10/18/2006 | CN1279928C Extracts and use of Leimo |
| 10/18/2006 | CN1279890C Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases |
| 10/17/2006 | USRE39355 Fusion protein with amino acid sequence of mature human insulin-like growth factor; synthesized in recombinant cell culture by host cells transformed with expression vectors; genetic engineering |
| 10/17/2006 | US7122656 MyD88S allows activation of JNK and AP-1, whereas the NF- kappa B pathway is completely blocked; used to obtain immunosuppression (e.g., in the case of transplantation); modulation of the expression of MyD88S can regulate the cellular responses to LPS and other immunological stimuli |
| 10/17/2006 | US7122655 Compositions involving M-RIP, and related methods for screening for anti-hypertensive agents, and uses thereof |
| 10/17/2006 | US7122654 Hybrid; adjust vascular system permeability |
| 10/17/2006 | US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene |
| 10/17/2006 | US7122651 Nucleic acid molecules encoding opioid growth factor receptors |
| 10/17/2006 | US7122649 Derivatized oligonucleotides having improved uptake and other properties |
| 10/17/2006 | US7122648 Isolated nucleic acids; binding to antibody; diagnosis of muscular disorders |
| 10/17/2006 | US7122646 Multivalent and multispecific binding proteins, their manufacture and use |
| 10/17/2006 | US7122644 Methods and compositions for inhibiting neoplastic cell growth |
| 10/17/2006 | US7122639 Chemokine alpha-2 antibodies |
| 10/17/2006 | US7122638 Hybridomas cell lines; viricides |
| 10/17/2006 | US7122635 Method and composition for angiogenesis inhibition |
| 10/17/2006 | US7122634 With an immunoreactivity-reducing amino acid of alanine, methionine, leucine; substituting for the naturally-occurring amino acid; correcting hemophilia in a patient deficient in factor VIII or having inhibitors to factor VIII |
| 10/17/2006 | US7122633 Natural killer stimulatory factor |
| 10/17/2006 | US7122632 Able to down-regulate IL-20; treating inflammatory diseases, psoriasis and inflammatory lung diseases |
| 10/17/2006 | US7122629 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays |
| 10/17/2006 | US7122627 Lactam inhibitors of Hepatitis C virus NS3 protease |
| 10/17/2006 | US7122625 Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 10/17/2006 | US7122624 Peptide for use in the treatment of asthma, emphysema, or other restrictive lung defects |
| 10/17/2006 | US7122623 Compounds and methods for modulating cell adhesion |
| 10/17/2006 | US7122622 Somatostatin analogue as peptide and chelating group covalently linked to N-terminal free amino group of peptide, wherein analogue carries 1-naphthylalanine or 3-benzothienylalanine residue in 3-position; diagnosis |
| 10/17/2006 | US7122621 Contains domains capable of forming amphipathic alpha helix, for cell lysis; site-directed mutagenesis; for treatment of leukemia or stomach carcinoma |
| 10/17/2006 | US7122620 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 10/17/2006 | US7122579 Eye treatments using synthetic thyroid hormone compositions |
| 10/17/2006 | US7122570 Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR) |
| 10/17/2006 | US7122524 Stimulating nerve growth, administering glycyl-L-phenylalanyl-L-prolineamide, N,N-diethyl-isoleucyl-phenylalanyl-L-proline ethylamide, N,N-diethyl-isoleucyl-isoleucyl-prolineamide; due to ischemic, traumatic or toxic origin |
| 10/17/2006 | US7122523 Methods for inhibiting tumor cell proliferation |
| 10/17/2006 | US7122522 Alpha-fetoprotein peptides and uses thereof |
| 10/17/2006 | US7122521 Collagen mimics |
| 10/17/2006 | US7122520 Nucleotide sequences coding polypeptide for use in the eating disorders |
| 10/17/2006 | US7122519 Didemnin analogs and fragments and methods of making and using them |
| 10/17/2006 | US7122517 Crystallized structure of type IV collagen NC1 domain hexamer |
| 10/17/2006 | US7122516 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics |
| 10/17/2006 | US7122515 Methods for treating a patient having Metabolic Syndrome |
| 10/17/2006 | US7122514 Coadministration of a lysostaphin or other antistaphylococcal agent which cleaves glycine crosslinks of the peptidoglycans of staphylococci cell walls and an antibiotic effective due to the cell wall activity, e.g., beta lactams and glycopeptides |
| 10/17/2006 | US7122506 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides |
| 10/17/2006 | US7122372 Peptide useful in immunomodulation |
| 10/17/2006 | US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases |
| 10/17/2006 | US7122360 Polypeptides, polynucleotides and uses thereof |
| 10/17/2006 | US7122358 Testis-specific tubulin tyrosine-ligase-like protein, BGS42 |
| 10/17/2006 | US7122357 Administering mixture of lipolytic, proteolytic and amylolytic enzymes such as pancreatin |
| 10/17/2006 | US7122356 Method for attachment of biomolecules to medical device surfaces |
| 10/17/2006 | US7122354 Therapy for Fabry's disease; genetic engineering; cloning; gene therapy |
| 10/17/2006 | US7122351 Dimerized PDGF-D and materials and methods for producing it |
| 10/17/2006 | US7122349 Human zven proteins |
| 10/17/2006 | US7122345 Used to treat blood, brain, urogenital, nervous system, sexual, bone, cardiovascular, gastrointestinal, skin disorders, cancer, bacterial/viral/fungi infections |
| 10/17/2006 | US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled |
| 10/17/2006 | US7122336 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 10/17/2006 | US7122335 Compounds and methods to enhance rAAV transduction |
| 10/17/2006 | US7122328 For therapy of arthritis |
| 10/17/2006 | US7122327 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state, and most particularly to specific biopolymer markers whose up-regulation, down-regulation, or relative presence in disease vs. normal states |
| 10/17/2006 | US7122324 Vitro methods for determining in vivo thrombotic events |
| 10/17/2006 | US7122311 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders |
| 10/17/2006 | US7122307 High throughput biological heart rate monitor that is molecularly determined |
| 10/17/2006 | US7122306 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 10/17/2006 | US7122302 Method for determining early HCV seroconversion |
| 10/17/2006 | US7122196 Compounds and methods for diagnosis of tuberculosis |
| 10/17/2006 | US7122194 Mixture of polypeptide with carrier |
| 10/17/2006 | US7122193 Comprising peptide analogues which have a half-life which is clearly superior to that of natural proteins or that of synthetic peptides which are or are not derived from these natural proteins |
| 10/17/2006 | US7122192 Porcine circoviruses, vaccines and diagnostic reagents |
| 10/17/2006 | US7122190 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells |
| 10/17/2006 | US7122189 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 10/17/2006 | US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody |
| 10/17/2006 | US7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 10/17/2006 | US7122181 Gene therapy; eye diseases |
| 10/17/2006 | CA2322502C Protease inhibitors in absorbent articles |
| 10/17/2006 | CA2317038C Supplement for dialysis patients |
| 10/17/2006 | CA2293808C Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 10/17/2006 | CA2195557C Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 10/17/2006 | CA2177179C Antagonists to chaperonin 10 |
| 10/14/2006 | CA2504076A1 Degradeable elastomeric network |
| 10/12/2006 | WO2006108035A1 Methods for treating immune disorders associated with graft transplantation with soluble ctla4 mutant molecules |
| 10/12/2006 | WO2006108023A2 Methods and compositions for modulating necdin function |
| 10/12/2006 | WO2006107990A2 Improving protein n-glycosylation of eukaryotic cells using dolichol-linked oligosaccharide synthesis pathway, other n-gylosylation-increasing methods, and engineered hosts expressing products with increased n-glycosylation |
| 10/12/2006 | WO2006107946A2 Bone cement compositions and the like comprising an rnaiii-inhibiting peptide |
| 10/12/2006 | WO2006107787A1 Methods and compositions related to chromatin-associated proteins and other factors |
| 10/12/2006 | WO2006107737A1 Treatment of asthma |
| 10/12/2006 | WO2006107719A2 Compositions and methods for the inhibition of dishevelled proteins |
| 10/12/2006 | WO2006107298A1 Methods for treating immune disorders associated with graft transplantation with soluble ctla4 mutant molecules |
| 10/12/2006 | WO2006107107A1 Myocardial protective agent comprising phospholipid liposome and method for prevention of myocardial disorder occurring under ischemia/reperfusion |
| 10/12/2006 | WO2006107093A1 Fibrinolytic agent, method of producing the same and method of using cucurbitaceous fruit |
| 10/12/2006 | WO2006107009A1 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device |
| 10/12/2006 | WO2006106912A1 Cancer-associated antigen analog peptide and utilization of the same |
| 10/12/2006 | WO2006106704A1 Composition for improvement of alcohol metabolism in blood |
| 10/12/2006 | WO2006106633A1 Uv-induced dermatitis inhibitor and atopic dermatitis inhibitor |
| 10/12/2006 | WO2006106599A1 Pharmaceutical for preventing and/or treating disease caused by abnormal enhancement of extracellular domain shedding |
| 10/12/2006 | WO2006106528A1 Novel peptides useful for treatment of alopecia |
| 10/12/2006 | WO2006106521A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| 10/12/2006 | WO2006106519A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
| 10/12/2006 | WO2006106164A1 Dermopharmaceutical or cosmetic composition comprising enkephalin-derived peptides for reducing and/or eliminating facial wrinkles |
| 10/12/2006 | WO2006105998A2 Treatment of cognitive and learning impairment |
| 10/12/2006 | WO2006105913A1 Tripeptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1 |
| 10/12/2006 | WO2006105912A2 Peptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1 |
| 10/12/2006 | WO2006105666A1 Administration of macrophage targeted formulations of compounds which modulate cholesterol-metabolizing enzymes for treatment of atherosclerosis |
| 10/12/2006 | WO2006105665A1 Hydrogel composition for modulation of topical inflammatory response |